Management of cardiovascular risk in patients receiving calcineurin inhibitors - A case report

Nephrology Dialysis Transplantation

Volumn 21, Issue SUPPL. 3, 2006, Pages

  Serón, Daniel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Calcineurin inhibitors; Cardiovascular risk; Myocardial infarction; Renal transplantation

Indexed keywords

ACENOCOUMAROL; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ATORVASTATIN; CALCINEURIN INHIBITOR; CARVEDILOL; CHOLESTEROL; CREATININE; CYCLOSPORIN A; FLUINDOSTATIN; GLUCOSE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; PREDNISONE; TACROLIMUS; TELMISARTAN; THALLIUM;

ACUTE GRAFT REJECTION; ADULT; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CARDIOVERSION; CHOLECYSTITIS; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DYSKINESIA; GINGIVA HYPERPLASIA; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEMATOCRIT; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOSIS;

ACENOCOUMAROL; AMIODARONE; ANGIOPLASTY; CALCINEURIN; CARBAZOLES; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; POSTOPERATIVE COMPLICATIONS; PRAVASTATIN; PREDNISONE; PROPANOLAMINES; RISK FACTORS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33745769506     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl302     Document Type: Article

References (24)

1. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313
2. Parfrey PA, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
3. Cosio FG, Kudva Y, van der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415-2421
4. Dimény EM. Cardiovascular disease after renal transplantation. Kidney Int 2002; 61 [Suppl 80]: S78-S84
5. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735-1743
6. Lindholm A, Albrechtsen D, Frödin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451-457
7. Fernández-Fresnedo G, Escallada R, Rodrigo E et al. The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 2002; 73: 1345-1348
8. Alonso A, Oliver J, Grupo Español de Estudio e la Nefropatía. Causes of death and mortality risk factors. Nephrol Dial Transplant 2004; 19 [Suppl 3]: Iii8-iii10
9. Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145-152
10. Holdaas H, Fellström B, Cole E et al. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin. Am J Transplant 2005; 5: 2929-2936
11. Dahan M, Viron BM, Faraggi M et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 1998; 54: 255-262
12. Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patient with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148
13. Fishbane S. Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol 2005; 16: 843-845
14. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. J Am Soc Nephrol 2003; 14: 431-439
15. Hernández D. Left ventricular hypertrophy after renal transplantation: New approach to a deadly disorder. Nephrol Dial Transplant 2004; 19: 1682-1686
16. Boots JMM, Christiaans MHL, van Hooff JP. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: Focus on the cardiovascular risk. Drugs 2004; 64: 2047-2073
17. Rama I, Cruzado JM, Gil-Vernet S et al. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: Long-term results. Transplantation 2005; 80: 164-168
18. Lang P, Pardon A, Audard V. Long-term benefit of mycophenolate mofetil in renal transplantation. Transplantation 2005; 79: S47-S48
19. Vitko S, Tedesco H, Eris J et al. Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies. Am J Transplant 2004; 4: 626-635
20. Pascual J, Marcén R, Ortuño J. Clinical experience with everolimus (Certican ®): Optimizing dose and tolerability. Transplantation 2005; 79 [9 Suppl]: S80-S84
21. Mulay AV, Hussain N, Fergusson D, Knoll GA. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials. Am J Transplant 2005; 5: 1748-1756
22. Eisen HJ, Tuzcu EM, Dorent R et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847-858
23. Eisen H, Starling R, Kobashigawa J. Incidence of MACE and economic burden in de novo heart transplant patients: A 4-year comparison of everolimus and azathioprine. Transplant Int 2005; 18: PO-111
24. Elloso MM, Azrolan N, Sehgal SN et al. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice. Am J Transplant 2003; 3: 562-569